Skip to main content
Clinical Trials/IRCT2016011626040N1
IRCT2016011626040N1Completed未知

Survey on Effect of Methadone to Buprenorphine Shift in the Maintenance Treatment on Profile of Gonadal Hormones and Semen Analysis of Infertile Men

Tehran University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
Male

Inclusion Criteria

  • men between 18 to 50 y/o; at least 6 months on Opioid Substitution Treatment & 3 months from last illegal opioid use; daily Methadone dose less than 60 mg/d; certification of therapist physician on stability & readiness of client for shifting from methadone to buprenorphine; diagnosis of methadone as the most important factor for undesirable hormonal & seminal analysis; written & signed informed consent form.
  • Exclusion criteria: evidence or signs of laps & relapse in buprenorphine treatment even with appropriate dose; absence from treatment more than 2 consecutive or 3 undulant weeks; absence from screening opioid urine test more than 2 consecutive or 3 undulant sessions; absence from hormonal & seminal analysis more than 2 weeks after appointed time; intolerance of methadone dose reduction for shifting to buprenorphine; intolerance of buprenorphine side effects.

Exclusion Criteria

  • Not provided

Investigators

Similar Trials